Shennon Biotechnologies

Recent Finacing

Seed

Recent Raise

$13M

Shennon Biotechnologies' single-cell functional screening platform profiles millions of immune cells within hours to identify rare activated T cells and discover TCR and antibody targets for cell therapy

Founded 2021

California, United States

11-50

Private

shennonbio.com

Highlights

Focus Areas

Biotechnology

Life Science

Medical

Recent Investors

Financials

$13M

Total Raised

1

Funding round

3

Investors

Team

Upgrade to view the team

See the team members at Shennon Biotechnologies.